Bottom line
Is FTHAX a good fund? The bottom line
FTHAX is the A share class of FullerThaler Behavioral Small-Cap Equity Fund, an actively managed small-cap mutual fund from Fidelity.
Annual fees run 1.07% — about $107 a year on every $10,000 invested, more expensive than 58% of small-cap funds we track.
It returned +5.2% over one year, +12.4% a year over five years (as of Dec 31, 2025, per its prospectus).
With $12.7 billion in net assets and 121 holdings, its largest position is Exelixis Inc (3.0%) and the top 10 make up 23.3% of the portfolio.
This share class carries a front-end sales charge of up to 5.75%; a no-load class or ETF alternative can avoid it.
What stands out
- 5-year return beat 96% of category peers
- Large and established ($12.7 billion)
What to watch
- Front-end sales load up to 5.75%
- 12b-1 marketing fee of 0.25% a year
Updated Nov 19, 2026
What FTHAX invests in
The FullerThaler Behavioral Small-Cap Equity Fund (the ?Small-Cap Equity Fund? or the ?Fund?) seeks long-term capital appreciation.
Under normal circumstances, the Fund seeks to achieve its objective by investing at least 80% of its net assets (plus borrowings for investment purposes) in common stocks of small capitalization (?small-cap?) companies based in the U.S. (?80% Policy?). The Fund must provide shareholders with 60 days? prior written notice if it changes its 80% Policy. The Fund considers a company to be based in the U.S. if it is publicly traded in the U.S. and it satisfies one or more of the following additional criteria: it is incorporated in the U.S., it is headquartered in the U.S., its reported assets are primarily located in the U.S., or it derives the majority of its revenue from the U.S. The Fund defines small-cap companies as companies whose market capitalizations are generally in the lowest 10% of total market capitalization or companies whose market capitalizations are smaller than or equal to…
From the fund's prospectus (filed Feb 2, 2026).
FTHAX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| FTHAX | +5.2% | +12.4% | — |
| Small-Cap median | +7.6% | +7.0% | +9.2% |
Source: Fund prospectus, as of Dec 31, 2025
What FTHAX costs
On a $10,000 investment, FTHAX's 1.07% expense ratio costs about $107 a year. The prospectus estimates $1,806 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.
FTHAX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | Exelixis Inc | 3.03% |
| 2 | Jazz Pharmaceuticals Plc | 2.97% |
| 3 | Emcor Group Inc | 2.70% |
| 4 | Match Group Inc | 2.42% |
| 5 | Applied Industrial Technologies Inc | 2.28% |
| 6 | Affiliated Managers Group Inc | 2.18% |
| 7 | Acuity Inc | 2.05% |
| 8 | Garrett Motion Inc | 2.00% |
| 9 | Encompass Health Corp | 1.87% |
| 10 | Borgwarner Inc | 1.84% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 23.3% of the fund. See all top 25 holdings and asset mix →